Leishmaniasis in humans: drug or vaccine therapy?

@inproceedings{Ghorbani2017LeishmaniasisIH,
  title={Leishmaniasis in humans: drug or vaccine therapy?},
  author={Masoud Ghorbani and Ramin Farhoudi},
  booktitle={Drug design, development and therapy},
  year={2017}
}
Leishmania is an obligate intracellular pathogen that invades phagocytic host cells. Approximately 30 different species of Phlebotomine sand flies can transmit this parasite either anthroponotically or zoonotically through their bites. Leishmaniasis affects poor people living around the Mediterranean Basin, East Africa, the Americas, and Southeast Asia. Affected regions are often remote and unstable, with limited resources for treating this disease. Leishmaniasis has been reported as one of the… CONTINUE READING
3
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 155 REFERENCES

Recent updates and perspectives on leishmaniasis.

  • Journal of infection in developing countries
  • 2015
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Strategic Evaluation of the 5 % Initiative

Matthieu Lacave, Léonor Rivoire, Francie Sadeski, Anne-Gaëlle Muths
  • 2018

Oral administration of synthetic selenium nanoparticles induced robust Th 1 cytokine pattern after HBs antigen vaccination in mouse model

S Noazin, F Modabber, A Khamesipour
  • J Infect Public Health
  • 2017

Similar Papers

Loading similar papers…